Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centers on the behaviors and needs of users. The clear benefits of UX offered in the retail and consumer sectors have been slow to percolate to other more complex sectors, such as the life sciences. As the benefits of adoption of UX come to be realized, we see steady and strong growth in the R&D life sciences sector… read more about this subject in this publication in Drug Discovery World. RockStep’s Julie Morrison co-authored the paper with the Pistoia Alliance UXLS group.